BEHRING DIAGNOSTICS GMBH has a total of 60 patent applications. Its first patent ever was published in 1988. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are DADE BEHRING MARBURG GMBH, MICROGENICS CORP and STRATEGIC DIAGNOSTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 35 | |
#2 | Canada | 10 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | Japan | 5 | |
#5 | Germany | 1 | |
#6 | Denmark | 1 | |
#7 | Norway | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Machines | |
#5 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Hermentin Peter | 7 |
#2 | Ullman Edwin F | 6 |
#3 | Fleckenstein Bernhard | 6 |
#4 | Brust Stefan | 5 |
#5 | Neipel Frank | 5 |
#6 | Brunn Albrecht V | 3 |
#7 | Habenstein Klaus | 3 |
#8 | Eberle Josef | 3 |
#9 | Seemann Gerhard | 3 |
#10 | Knapp Stefan | 3 |
Publication | Filing date | Title |
---|---|---|
US5753233A | Seroreactive epitopes on proteins of human papilloma-virus (HPV) 18 | |
DE19505262A1 | Retrovirus from the HIV group and its use |